Proprotein Convertase Subtilisin/Kexin Type 9: From Biology to Therapeutic Targeting in Cardiovascular Disease. (PubMed, Eur J Clin Invest) - Oct 20, 2026 - "PCSK9 is a multifaceted protein with roles extending far beyond LDL-C regulation. Understanding its diverse interactions is crucial for optimizing treatment in cardiovascular disease and potentially expanding its therapeutic application to metabolic and infectious conditions."
Journal • Review • Atherosclerosis • Cardiovascular • Dyslipidemia • Heart Failure • Infectious Disease • Metabolic Disorders • Oncology
|
|
Alberico L Catapano; Amirbahman Zeynali; Bianca S Daraban; Davide Barbarossa; Francesca Protopapa; Francesco M Esposito; Irina F Tudorache; Riccardo Rizzo
|